1. Home
  2. VIR vs KSS Comparison

VIR vs KSS Comparison

Compare VIR & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.70

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Kohl's Corporation

KSS

Kohl's Corporation

HOLD

Current Price

$15.33

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
KSS
Founded
2016
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
VIR
KSS
Price
$8.70
$15.33
Analyst Decision
Strong Buy
Sell
Analyst Count
7
15
Target Price
$19.43
$15.31
AVG Volume (30 Days)
1.6M
5.0M
Earning Date
05-06-2026
05-28-2026
Dividend Yield
N/A
3.58%
EPS Growth
17.49
142.86
EPS
N/A
N/A
Revenue
$68,556,000.00
N/A
Revenue This Year
$270.22
N/A
Revenue Next Year
N/A
$0.21
P/E Ratio
N/A
$6.70
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$8.09
52 Week High
$11.66
$25.22

Technical Indicators

Market Signals
Indicator
VIR
KSS
Relative Strength Index (RSI) 41.56 56.55
Support Level $8.48 $14.70
Resistance Level $10.10 $16.74
Average True Range (ATR) 0.42 0.82
MACD -0.02 0.33
Stochastic Oscillator 8.63 76.65

Price Performance

Historical Comparison
VIR
KSS

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About KSS Kohl's Corporation

Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.

Share on Social Networks: